In Vitro Diagnostics IVD Market Worth US$ 77 billion by 2022

New York, February 13: Market Research Engine has published a new report titled as “Global In Vitro Diagnostics IVD Market By Product Analysis (Reagents, Instruments, Software & Services); By Technique Analysis (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry); By Application Analysis (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases) By End User Analysis (Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care) and By Regional Analysis – Global Forecast by 2016 - 2022”

How Big is the Global In Vitro Diagnostics IVD Market?

The Global In Vitro Diagnostics IVD Market is expected to exceed more than US$ 77 billion by 2022 and will grow at a CAGR of more than 5% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/global-in-vitro-diagnostics-ivd-market

In vitro diagnostics (IVD) is the approach in which scientific devices and reagents are used to take a look at specimens. Such as blood, urine, stool, tissues and other frame fluids, which can be derived from the human body to detect illnesses, situations and infections? The tests can be carried out in hospitals, standalone laboratory based lab. Number of the giant technology included in vitro diagnostics include polymerase chain reaction (pcr), sequencing technology, microarray techniques and mass spectrometry, which might be used for take a look at sample instruction. Incessant improvements in IVD product design and generations have endorsed medical doctors and researchers to shift their awareness from traditional diagnostic strategies to customized drug treatments.

The major driving factors of Global In Vitro Diagnostics IVD Market are as follows:

• Increasing demand for technically advanced diagnostic devices
• Technical expansion to develop high sensitivity point of care hematology testing
• Improved disposable income of customers gives high expansion potential for IVD market

The restraining factors of Global In Vitro Diagnostics IVD Market are as follows:

• Strict government rules
• Inauspicious reimbursement policies

The Global In Vitro Diagnostics IVD Market is segmented on the lines of its product, technique, application, end user and regional. Based on product segmentation it covers reagents, instruments and software & services. Technique segmentation is further classified into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry and other IVD techniques. Immunodiagnostics is classified into enzyme-linked immunosorbent assay, enzyme-linked immunospot, rapid tests, western blot and radioimmunoassay. Under molecular diagnostics segmentation it covers polymerize chain reaction, hybridization, isothermal nucleic acid technology, microarray, DNA diagnostics and others. Clinical Chemistry is segmented into basic metabolic panel, lipid profile, liver panel, electrolyte panel, thyroid function panel and specialty chemicals. Based on application segmentation it covers infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases and other indications. Under end user segmentation it covers standalone laboratory, hospitals, academic &medical schools, point of care and others. The Global In Vitro Diagnostics IVD Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Download Free Sample Report: https://www.marketresearchengine.com/requestsample/global-in-vitro-diagnostics-ivd-market

This report provides:

1) An overview of the global market for In Vitro Diagnostics IVD and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.

3) Identifications of new market opportunities and targeted promotional plans for In Vitro Diagnostics IVD.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Global In Vitro Diagnostics IVD Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Affymetrix, Inc., AlereInc, Biomerieux, Danaher Corporation., Roche Diagnostics, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG., Arkray, Inc., Sysmex Corporation, Johnson & Johnson Pvt. Ltd. And Siemens AG. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Global In Vitro Diagnostics IVD Market has been segmented as below:

By Product Analysis

• Reagents
• Instruments
• Software & Services

By Technique Analysis

• Immunodiagnostics
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Enzyme-Linked ImmunoSpot (ELISPOT)
o Rapid Tests
o Western blot
o Radioimmunoassay (RIA)
• Blood Testing
• Molecular Diagnostics
o Polymerize Chain Reaction (PCR)
o Hybridization
o Isothermal Nucleic Acid Technology (INAAT)
o Microarray
o DNA diagnostics
o Others
• Tissue Diagnostics
• Clinical Chemistry
o Basic metabolic panel
o Lipid profile
o Liver panel
o Electrolyte panel
o Thyroid function panel
o Speciality chemicals
• Other IVD Techniques

By Application Analysis

• Infectious Diseases
• Cancer
• Cardiac Diseases
• Immune System Disorders
• Nephrological Diseases
• Gastrointestinal Diseases
• Other Indications

By End User Analysis

• Standalone Laboratory
• Hospitals
• Academic & Medical Schools
• Point of Care
• Others

By Regional Analysis

• North America
• Europe
• Asia-Pacific
• Rest of the World

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.